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Macrophage apoptosis is an important component of
the innate immune defense machinery (against patho-
genic mycobacteria) responsible for limiting bacillary
viability. However, little is known about the mechanism
of how apoptosis is executed in mycobacteria-infected
macrophages. Apoptosis signal-regulating kinase 1
(ASK1) was activated in Mycobacterium avium-treated
macrophages and in turn activated p38 mitogen-acti-
vated protein (MAP) kinase. M. avium-induced macro-
phage cell death could be blocked in cells transfected
with a catalytically inactive mutant of ASK1 or with
dominant negative p38 MAP kinase arguing in favor of a
central role of ASK1/p38 MAP kinase signaling in apo-
ptosis of macrophages challenged with M. avium. ASK1/
p38 MAP kinase signaling was linked to the activation of
caspase 8. At the same time, M. avium triggered caspase
8 activation, and cell death occurred in a Fas-associated
death domain (FADD)-dependent manner. The death
signal induced upon caspase 8 activation linked to mi-
tochondrial death signaling through the formation of
truncated Bid (t-Bid), its translocation to the mitochon-
dria and release of cytochrome c. Caspase 8 inhibitor
(z-IETD-FMK) could block the release of cytochrome c as
well as the activation of caspases 9 and 3. The final steps
of apoptosis probably involved caspases 9 and 3, since
inhibitors of both caspases could block cell death. Of
foremost interest in the present study was the finding
that ASK1/p38 signaling was essential for caspase 8 ac-
tivation linked to M. avium-induced death signaling.
This work provides the first elucidation of a signaling
pathway in which ASK1 plays a central role in innate
immunity.
Mycobacterium avium is an intracellular facultative bacte-
rium that proliferates inside host macrophages (1, 2). It causes
severe pulmonary and disseminated disease in immunocom-
promised hosts, especially in individuals with AIDS (3). The
bacterium poses a threat in these individuals particularly in
view of the fact that 40–50% of all patients with M. avium
infection are refractory to conventional antibiotics and antimy-
cobacterial drugs (4). The innate immune response to mycobac-
teria is initiated when the bacteria interact with cell surface
receptors. This results in subsequent internalization of the
mycobacterium within the macrophage. The macrophage rep-
resents the first line in innate immune defense against myco-
bacteria. In macrophages infected with pathogenic mycobacte-
ria, apoptotic death is associated with a reduction in bacillary
viability (5–8). On the other hand, the success of virulent
mycobacteria as pathogens is attributed largely to their ability
to survive and multiply within macrophages for extended pe-
riods of time. Mycobacteria live and proliferate within phago-
somes, which unlike those containing other bacteria, are ar-
rested in their maturation (9–11), lack lysosomal markers (12)
and fail to be acidified (13). The balance between the pathogen-
eliminating mechanisms employed by the macrophage, and the
survival pathways used by the mycobacterium determines the
fate of the organism. In this context it is of foremost importance
to understand the pathways of macrophage cell death upon
challenge with mycobacteria and the strategies used by the
pathogen to offset cell death and prolong its own survival
within macrophages.
Apoptosis is an orchestrated suicide program, that among its
other functions, enables an organism to remove invading
pathogens without causing an inflammatory response. The key
morphological alterations of apoptosis are mediated by a family
of cysteine proteases called the caspases, which are activated
by proteolytic cleavage (14–16). Activation of caspases is
achieved via two principal signaling pathways, namely the
extrinsic and intrinsic death pathways (17, 18). The extrinsic
death pathway involves the ligation of death receptors (CD95/
Fas; tumor necrosis factor receptor) that leads to the recruit-
ment of adaptor molecules such as Fas-associated death do-
main (FADD),1 and pro-caspase 8 or procaspase 10 into a
death-inducing signaling complex (DISC) (19, 20). Adaptor
molecules such as FADD and TRADD activate caspase 8
through proximal interactions between their death effector do-
mains (DED) (21). Activated caspase 8 can then cleave and
activate downstream effector caspases such as caspase 3 and
caspase 7 (22–24). In the intrinsic (or mitochondrial) death
pathway, mitochondria release several death-promoting fac-
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tors including cytochrome c (cyt c) (25), apoptosis-inducing
factor (AIF) (26), and Smac (DIABLO) (27, 28) in response to
death-inducing signals via the Bcl-2 family of proteins (29). In
the cytosol, cyt c interacts with apoptotic protease-activating
factor (Apaf-1). On binding cyt c, an ATP/dATP-binding oli-
gomerization domain within Apaf-1 mediates Apaf-1 oligomer-
ization (30, 31). The oligomerized complex (apoptosome) then
binds procaspase 9 and facilitates processing of caspase 9 zy-
mogens (32). Activated caspase 9 subsequently activates effec-
tor caspases (33).
There is a cross-talk between the extrinsic and intrinsic
death pathways. One mechanism for this cross-talk is the
cleavage of Bid by caspase 8. Bid is a BH3-domain-only mem-
ber of the Bcl-2 family of death-regulating proteins (34). The
BH3 domain-only family are upstream activators of apoptosis
that signal to downstream proapoptotic Bcl-2 family members
such as Bax or Bak leading to their oligomerization at the
mitochondria. Activated caspase 8 can cleave p22 Bid to gen-
erate a p15 active truncated Bid (t-Bid) fragment, which is then
targeted to the mitochondria (35). Cleavage of Bid to the mito-
chondrially active, t-Bid, is a feature of caspase 8-mediated
apoptosis induced via death receptors (36, 37) which enables
amplification of the apoptotic signal through the mitochondrial
release of cyt c (38)
The mitogen-activated protein (MAP) kinase cascade is one
of the evolutionarily conserved phosphorylation-regulated pro-
tein kinase cascades, which is involved in controlling the deci-
sion of cell survival or cell death. Apoptosis signal-regulating
FIG. 1. ASK1 and p38 MAP kinase
are activated upon challenge of
J774A-1 macrophages with M. avium.
J774A-1 macrophages were incubated
with M. avium at a MOI of 10 for different
periods of time (panel A), or J774A-1
macrophages were incubated with
M. avium at different MOI for 3 h (panel
B). Whole cell lysates were prepared,
ASK1 was immunoprecipitated, and in
vitro ASK1 kinase activity was deter-
mined using MBP as substrate as de-
scribed under “Experimental Proce-
dures.” Panel C, J774A-1 macrophages
were left untreated or treated with NAC
at different concentrations for 60 min.
Cells were washed and then incubated
without or with M. avium at an MOI of 10
for 3 h. ASK1 activity was determined in
the lysates as described above. In each
case the bottom panel is a representative
Western blot with anti-ASK1 to show that
the same amount of ASK1 was present in
each sample. Panel D, J774A-1 macro-
phages were transfected with wild-type
ASK1(WT) or a catalytically inactive mu-
tant of ASK1(KM) followed by incubation
without or with M. avium at an MOI of 10
for 3 h. In separate experiments cells
transfected with ASK1(WT) were treated
with vehicle or with SB203580 (10 M) for
60 min before incubation with M. avium.
Whole cell lysates were prepared, fol-
lowed by immunoblotting with anti-phos-
pho-p38 MAP kinase antibodies. The
lower blot shows that the same amount of
p38 MAP kinase was present in each sam-
ple. Panel E, J774A-1 macrophages were
transfected with empty vector or domi-
nant-negative FADD (FADD(dn)) fol-
lowed by incubation without or with
M. avium at an MOI of 10 for 3 h. Immu-
noblots of whole cell lysates were probed
with anti-phospho-ASK1 or anti-phospho-
p38 MAP kinase antibodies. The right
hand panels in each case represent the
densitometric analysis of autoradiograms
(Error bars represent S.E. from three in-
dependent experiments).
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kinase 1 (ASK1) is a member of the MAP kinase kinase kinase
(MAPKKK) family, which plays a role in stress-induced apo-
ptosis principally through activation of the JNK or the p38
MAP kinase signaling cascades (39–42)
Mycobacterium tuberculosis and M. avium are both faculta-
tive intracellular bacteria that reside and replicate inside the
macrophages of the infected host. The relationship between the
course of mycobacterial infection in vivo and the pro- or anti-
apoptotic cell signaling within the host is still unclear. How-
ever, in vitro studies suggest that induction of apoptosis in
macrophages is the host cell strategy to eliminate the invading
pathogen, whereas prevention of programmed cell death can
result in the possibility of prolonged intracellular survival of
mycobacteria. The organism therefore tries to commandeer the
host cell signaling machinery to offset cell death (43). The
mechanisms of apoptotic cell death in macrophages challenged
with mycobacteria are largely unknown, other than reports of
apoptotic signaling involving both Fas and TNF receptor (5,
58). The present study was undertaken with the objective of
understanding the signaling pathways mediating macrophage
apoptosis upon challenge with M. avium. Our results suggest
that M. avium-induced apoptosis involves FADD-mediated ac-
tivation of caspase 8, cleavage of t-Bid, release of cyt c and
activation of caspases 9 and 3. Further, we identify the ASK1/
p38 signaling pathway as being critical to caspase 8 activation
and subsequent M. avium-induced cell death.
EXPERIMENTAL PROCEDURES
Reagents—Antibodies against total MAP and phosphospecific ki-
nases, cleaved caspase 3, PARP, and caspase 9 were purchased from
Cell Signaling Technology, Beverley, MA. Antibodies against ASK1, cyt
c, -actin, and Bid, and protein A/G (plus)-agarose were purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Phospho-ASK1-spe-
cific antibody was a gift from Hidenori Ichijo, Tokyo Medical and Dental
University, Tokyo, Japan. N-acetylcysteine (NAC), SB203580, U0126,
z-DEVD-FMK, z-LEHD-FMK, z-IETD-FMK, Ac-DEVD-pNA, Ac-
LEHD-AFC, Ac-IETD-AFC, and protease inhibitors were from CN Bio-
sciences (San Diego, CA).
Culture of the Murine Macrophage-like Cell Line J774A-1—Media
and supplements were purchased from Invitrogen. The murine macro-
phage cell line J774A-1 was obtained from the National Centre for Cell
Science, Pune and maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% heat-inactivated fetal bovine serum, 100
units/ml penicillin and 100 g/ml streptomycin in a humidified atmo-
sphere containing 5% CO2. Dishes were washed to remove non-adher-
ent cells. Adherent cells were 95% viable as determined by trypan
blue dye exclusion.
Growth of M. avium—M. avium (NCTC 8562) was obtained from the
All India Institute of Medical Sciences New Delhi), grown in Middle-
brook 7H9 broth (Difco, Detroit, MI) supplemented with oleic acid-
albumin-dextrose (OADC) supplement and 0.04% Tween 80 until mid-
log phase, harvested, washed, and resuspended in a small volume of
phosphate-buffered saline containing 0.04% (v/v) Tween 80. The sus-
pension was briefly sonicated until no bacterial clumps were visualized
by microscopy. The preparation was diluted to a concentration of 2 
108 CFU/ml in 10% glycerol and stored in aliquots at 80 °C. Freshly
thawed aliquots were used no more than once.
Plasmid Constructs and Transient Transfections—HA-tagged wild-
type ASK1 (ASK1, WT) and a catalytically inactive mutant (K709M) of
ASK1 (ASK1, KM) were obtained from Hidenori Ichijo. FLAG-tagged p8
MAPK and its dominant-negative mutant (p38 (agf)) were obtained
from Roger Davis, University of Massachusetts Medical School, Worces-
ter, MA, and dominant-negative FADD (FADD (dn)) was from Claudius
Vincenz, University of Michigan, Ann Arbor, MI. 2  106 cells were
FIG. 2. M. avium-induced cell death of J774A-1 macrophages measured as the release of histone using ELISA. Panel A, cells were
incubated with M. avium at an MOI of 10 and histone release was measured after different periods of time using the Cell Death ELISA kit from
Roche Applied Science as described under “Experimental Procedures.” Panel B, J774A-1 macrophages were transfected with: ASK1: WT or KM;
p38: WT or agf; empty vector or FADD(dn); followed by incubation without or with M. avium at an MOI of 10 for 18 h. Panel C, cells were left
untreated or treated with the cell-permeable MAP kinase inhibitors U0126 or SB203580, or with NAC at the indicated concentrations for 60 min;
followed by removal of the inhibitors and incubation without or with M. avium at an MOI of 10 for 18 h. Panel D, cells were left untreated or treated
with the cell-permeable irreversible caspase inhibitors (50 M); z-IETD-FMK (for caspase 8), or z-DEVD-FMK (for caspase 3), or z-LEHD-FMK (for
caspase 9) for 60 min followed by removal of the inhibitors and incubation without or with M. avium at an MOI of 10 for 18 h. In each case, bacteria
were removed, cells were washed, lysed, and cell death was measured using the Cell Death ELISA kit from Roche Applied Science as described
under “Experimental Procedures.” Values are given as the means  S.E. of three independent experiments.
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plated in each well of 6-well plates, and cells were transfected with 2 g
of plasmid (empty vectors or recombinants) using the Effectene reagent
(Qiagen) in Dulbecco’s modified Eagle’s medium with 10% fetal bovine
serum according to the manufacturer’s instructions. -Galactosidase
reporter plasmid was used to normalize transfection efficiencies.
Infection and Preparation of Cell Lysates—J774A-1 cells were cul-
tured in 24-well tissue culture plates at 4  105 cells per well and were
infected with M. avium at a multiplicity of infection (MOI) of 10 or as
stated under the legends to figures. Cells were lysed with 1% (v/v)
Triton X-100, and the lysate was diluted and plated on Middlebrook
7H10 agar to quantitate the number of viable intracellular bacteria.
The incubation of J774–1 with M. avium at a bacteria/macrophage ratio
of 10:1 for 6 h led to infection of 50% of the cells. The viability of the
control monolayers was monitored during the experiments by the
trypan blue exclusion method. The viability was 95% in all the exper-
iments described. After incubation with M. avium, the wells were
washed with ice-cold PBS to remove free bacteria. Cells were lysed with
lysis buffer (20 mM Tris-HCl (pH 7.4), 1% (v/v) Nonidet P-40, 10% v/v
glycerol, 137 mM NaCl, 20 mM NaF, 1 mM EDTA, 40 mM sodium
-glycerophosphate, 4 g/ml each of leupeptin, pepstatin, and aproti-
nin, 1 mM Na3VO4 1 mM pefabloc, 1 mM benzamidine) on ice for 15 min.
Cell lysates were boiled for 5 min after the addition of 5 Laemmli
sample buffer and subjected to Western blotting. Where necessary,
J774A-1 cells were first treated with pharmacological inhibitors or
vehicle (Me2SO) alone, prior to incubation with M. avium. When per-
forming Western blotting for detection of caspases, 6  106 cells were
pelleted and freeze-thawed thrice in 20 l of cell extraction buffer (50
mM PIPES/NaOH (pH 6.5), 2 mM EDTA, 0.1% (w/v) CHAPS, 5 mM
dithiothreitol, 20 g/ml leupeptin, 10 g/ml pepstatin, 10 g/ml apro-
tinin, 1 mM pefabloc). The lysates were centrifuged at 10,000  g for 5
min at 4 °C, and the supernatants were collected for detection of
caspases.
Western Blotting—Proteins were separated on SDS-polyacrylamide
gels and then transferred electrophoretically to polyvinylidene difluo-
ride membranes. The blots were blocked with 5% nonfat dry milk in
Tris-buffered saline (TBS) for 1 h at room temperature and subse-
quently incubated overnight at 4 °C with primary antibodies in TBS-
Tween 20 (1%, v/v) (TBST) with 5% (w/v) bovine serum albumin. Fol-
lowing three washes of 5 min each with TBST, the blots were incubated
with horseradish peroxidase-conjugated goat anti-rabbit IgG (Cell Sig-
naling Technology) (or appropriate secondary antibody) in blocking
buffer for 1 h at room temperature. After three washes with TBST, the
blots were developed with BM chemiluminescence reagent (Roche Ap-
plied Science) and exposed to x-ray film (Kodak XAR5).
ASK1 Kinase Assay—After treatment, cells were washed with ice-
cold PBS, and lysed with lysis buffer containing 20 mM Tris-HCl (pH
7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%(v/v) Triton X-100, 1%
sodium deoxycholate, 0.5 mM sodium pyrophosphate, 1 mM sodium
FIG. 3. Western blot analysis of M. avium-induced caspase activation in J774A-1 macrophages. J774A-1 macrophages were incubated
with M. avium at an MOI of 10 for different periods of time (panel A), or J774A-1 macrophages were treated with z-DEVD-FMK (50 M) or
z-LEHD-FMK (50 M) for 60 min prior to incubation without or with M. avium (panel B) at an MOI of 10 for 6 h. Cell lysates were prepared as
described under “Experimental Procedures.” Cleaved caspase 3 (17 kDa) was detected by Western blotting using antibodies against cleaved caspase
3. Panel C, J774A-1 macrophages were incubated with M. avium at an MOI of 10 for different periods of time, or J774A-1 macrophages were treated
with z-DEVD-FMK (50 M) 60 min (last two lanes) prior to incubation without or with M. avium at an MOI of 10 for 6 h. Cell lysates were prepared
as described under “Experimental Procedures.” Cleaved PARP (89 kDa) was detected by Western blotting using antibodies against cleaved PARP.
Panel D, J774A-1 macrophages were either not transfected (first two lanes) or transfected with ASK1(WT) or with ASK1(KM) followed by
incubation without or with M. avium at an MOI of 10 for 6 h. Cleaved caspase 3 (17 kDa) was detected as described under panel A. Panel E, J774A-1
macrophages were incubated with M. avium at an MOI of 10 for different periods of time or J774A-1 macrophages were treated with z-IETD-FMK
(50 M) for 60 min (last two lanes) prior to incubation without or with M. avium at an MOI of 10 for 6 h. Cell lysates were prepared as described
under “Experimental Procedures.” Procaspase 9 (52 kDa) and cleaved caspase 9 (37 kDa) was detected by Western blotting using antibodies against
caspase 9. Panel F, J774A-1 macrophages were either not transfected (first two lanes), or transfected with ASK1(WT) or with ASK1(KM) followed
by incubation without or with M. avium at an MOI of 10 for 6 h. Caspase 9 was detected as described under panel E. Panel G, J774A-1 macrophages
were treated with z-IETD-FMK (50 M) or z-DEVD-FMK (50 M) or SB203580 (10 M) for 60 min prior to incubation without or with M. avium
at an MOI of 10 for 6 h. Cell lysates were prepared as described under “Experimental Procedures.” Procaspase 8 (55 kDa) and cleaved caspase 8
(20 kDa) were detected by Western blotting using antibodies against caspase 8. Panel H, J774A-1 macrophages were transfected with empty vector
or with FADD (dn) followed by incubation without or with M. avium at an MOI of 10 for 6 h. Caspase 8 was detected as described under panel G.
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-glycerophosphate, 1 mM Na3VO4, and 1 g/ml leupeptin. Lysates were
centrifuged at 10,000  g for 10 min at 4 °C. The supernatant (equiv-
alent to 200 g of protein) was incubated overnight at 4 °C on a rocker
with rabbit polyclonal ASK1 antibody. 10 l of protein A/G plus agarose
was subsequently added and incubated at 4 °C for an additional 3 h.
The beads were washed twice with lysis buffer and twice with kinase
buffer (25 mM Tris-HCl, pH 7.5, 5 mM Na--glycerophosphate, 2 mM
dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2). The pellet was washed
once with kinase buffer without protease inhibitors. The beads were
then incubated in 20 l of kinase buffer in the presence of 0.5 Ci of
[-32P]ATP (specific activity 3,000 Ci/mmol) with 1 g of myelin basic
protein (MBP) as substrate at 30 °C for 15 min. The reaction was
stopped by adding protein gel denaturing buffer. After SDS-PAGE and
autoradiography, the band intensities were quantified by densitometric
scanning of the autoradiograms.
Cell Death ELISA—J774A-1 cells were plated (6  104 cells/plate) on
96-well plates. Cells were either treated with inhibitors or transfected
with different plasmid constructs prior to incubation without or with
M. avium. Cell death was detected with the cell death detection ELISA
plus kit (Roche Applied Science) according to the manufacturer’s protocol.
Caspase Activity Assays—Cells (6  105) were lysed by incubating
with 25 l of lysis buffer (25 mM HEPES (pH 7.5), 2 mM EDTA, 0.1%
(w/v) CHAPS, 5 mM dithiothreitol, 10 g/ml pepstatin, 10 g/ml apro-
tinin, 20 g/ml leupeptin, 1 mM pefabloc) on ice for 15 min. The super-
natant was kept frozen at 70 °C until used. Lysate (20–100 g of
protein) was taken in 100 l of assay buffer containing 50 mM HEPES
(pH 7.5), 100 mM NaCl, 10 mM dithiothreitol, 10% glycerol, 0.1%
CHAPS, and 200 M substrate. For measuring caspase 3 activity, sam-
ples were incubated at 37 °C for 4 h with Ac-DEVD-pNA as substrate,
and absorbance at 405 nm was measured. Caspase 8 and 9 activities
were measured using the fluorigenic substrates Ac-IETD-AFC and Ac-
LEHD-AFC respectively. Fluorescence of the released AFC was meas-
ured using excitation and emission wavelengths of 360 and 530 nm,
respectively.
Isolation of Cytosol and Mitochondrial Fractions for Detection of Cyt
c and Bid—After treatments, 18  106 cells were washed with ice-cold
PBS, and cell pellets were resuspended in 400 l of resuspension buffer
(20 mM HEPES (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA, 1 mM pefabloc, 10 g/ml leupeptin, 10 g/ml aprotinin, 150 mM
sucrose). The cells were broken with 20 passages through a 26-gauge
needle, and the homogenate was centrifuged at 750  g for 10 min, to
remove nuclei and unbroken cells. The mitochondrial pellet was ob-
tained by centrifugation at 10,000 g for 15 min and resuspended in 40
l of resuspension buffer (20 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM
pefabloc, 10 g/ml leupeptin, 10 g/ml aprotinin). The supernatant was
centrifuged at 100,000 g for 60 min at 4 °C. The supernatant obtained
was the cytosolic fraction. Cytosolic and mitochondrial fractions (20 g
of protein) were used for quantification of cyt c and Bid, respectively.
Prior to Western blotting, protein concentrations were assayed and all
samples were normalized to equal protein concentrations. Blots were
stripped and reprobed for -actin expression.
RESULTS
M. avium Induces Activation of ASK1 and p38 MAP Kinases
in J774A-1 Macrophages—Taking into account the facts that
challenge of macrophages with M. avium leads to macrophage
apoptosis (44) through a process in which oxidative stress plays
a key role and that ASK1 is required for oxidative stress-
induced apoptosis involving the stress-activated MAP kinases
p38 and JNK, we asked the question whether ASK1 is acti-
vated in response to incubation of J774A-1 macrophages with
M. avium. Incubation of macrophages with M. avium at an
MOI of 10 led to a time-dependent increase in ASK1 kinase
activity as evidenced by in vitro phosphorylation of MBP (Fig.
1, panel A). ASK1 kinase activity increased directly with in-
creasing MOI (Fig. 1, panel B). Pretreatment of cells with NAC
FIG. 4. M. avium-induced caspase activity assays in J774A-1 macrophages. J774A-1 macrophages were incubated without or with
M. avium at an MOI of 10 for 6 h. Cell lysates were prepared and caspase activities were determined using 20 g of protein with the fluorigenic
substrates Ac-LEHD-AFC (for caspase 9) (panel A) Ac-IETD-AFC (for caspase 8) (panels C, D, and E) or the colorimetric substrate Ac-DEVD-pNA
(for caspase 3) (panel B), as described under “Experimental Procedures.” Cells were left untreated or treated with the caspase 8 inhibitor
(z-IETD-FMK) (panels A and B) or the caspase 9 inhibitor (z-LEHD-FMK) (panel B) before challenge without or with M. avium. Panel C, cells were
transfected with empty vector or FADD (dn) before incubation without or with M. avium. Panel D, cells were left untreated or treated with different
concentrations of the p38 MAP kinase inhibitor SB203580 prior to incubation without or with M. avium. Panel E, cells were transfected with
ASK1(WT) or ASK1(KM) followed by incubation without or with M. avium. Where indicated ASK1(WT)-transfected cells were treated with
SB203580 at different concentrations prior to incubation without or with M. avium. Cleavage activities are expressed relative to that of uninfected
and untreated cells. Results represent the mean of three separate experiments  S.E.
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prior to challenge with M. avium abrogated the M. avium-
induced ASK1 activation (Fig. 1, panel C), suggesting the prob-
able involvement of reactive oxygen species (ROS) in ASK1
activation mediated by M. avium. Control experiments showed
that equal amounts of precipitated ASK1 were used to assay
kinase activity. In subsequent experiments, cells were trans-
fected with wild type or a catalytically inactive mutant (KM) of
ASK1, prior to challenge with M. avium. Whereas p38 MAP
kinase activation was observed in ASK1(wt)-transfected cells
challenged with M. avium as evidenced for phosphorylation of
p38 MAP kinase (Fig. 1, panel D), no activation of p38 MAP
kinase was evident in cells transfected with ASK1(KM). This
suggested that ASK1 mediates the activation of p38 MAP ki-
nase in M. avium-challenged macrophages. This effect was
abrogated when cells were pretreated with the pharmacological
inhibitor of p38 MAP kinase, SB203580 (45) (Fig. 1, panel D).
M. avium-induced Macrophage Cell Death—Taking into ac-
count previous reports that M. avium induces apoptosis of
macrophages, and our results showing M. avium-induced
ASK1 activation, we asked the question whether ASK1-de-
pendent signaling is linked to death of J774A-1 macrophages
challenged with M. avium. M. avium induced macrophage cell
death in a time-dependent manner (Fig. 2, panel A) as meas-
ured using histone ELISA. Transfection of cells with catalyti-
cally inactive ASK1 abrogated M. avium-induced cell death
(Fig. 2, panel B). Dominant-negative p38 MAP kinase exerted a
similar effect, supporting the view that cell death was depend-
ent on ASK1/p38 MAP kinase signaling. This was further sup-
ported by the fact that SB203580 could inhibit M. avium-
induced cell death in a dose-dependent manner (Fig. 2, panel
C), whereas U0126, an inhibitor of ERK 1/2 MAP kinase was
without effect. In order to evaluate the role of FADD-mediated
signaling in M. avium-induced apoptosis, cells were transfected
with dominant-negative FADD (FADD(dn)) prior to challenge
with M. avium. FADD (dn) abrogated M. avium-induced cell
death (Fig. 2, panel B). FADD was not upstream of ASK1/p38
MAP kinase signaling since M. avium-induced ASK1 and p38
MAP kinase activation (assessed by probing Western blots with
phospho-ASK1 and phospho-p38-specific antibodies) occurred
even in FADD (dn)-transfected cells (Fig. 1, panel E). Cell
death was also inhibited by treatment with NAC (Fig. 2, panel
C). It is presently unclear how NAC regulates ASK1 activation
and cell death in this case. ROS may oxidize thioredoxin thus
dissociating it from ASK1 leading to ASK1 activation (46). It is
also possible that a sequential signaling pathway links ROS
production to ASK1 activation.
Members of the caspase family are crucial mediators of apo-
ptosis. Therefore the role of caspases, in M. avium-mediated
cell death was evaluated using specific inhibitors for different
caspases. As evident from Fig. 2 (panel D), the involvement of
FIG. 5. M. avium-induced cleavage of Bid and release of cyt c from the mitochondria. Panel A, J774A-1 macrophages were incubated
without (control) or with M. avium at an MOI of 10 for different periods of time (upper blot). In separate experiments, cells were either treated with
the caspase 8 inhibitor z-IETD-FMK (50 M) (middle blot) or transfected with empty vector or FADD (dn) (lower blot) prior to incubation without
or with M. avium at an MOI of 10 for 6 h. Cells were processed to obtain mitochondrial fractions as described under “Experimental Procedures,”
and Bid was detected by Western blotting. Panel B, untreated cells or cells treated with caspase 8 inhibitor were incubated with M. avium as
described under panel A. Cyt c and actin were detected in the cytosolic fraction by SDS-PAGE followed by Western blotting. Panel C, cells were
transfected with p38 (wt) or p38 (agf), ASK1(WT) or ASK1(KM)) (panel C), FADD (dn), or empty vector followed by incubation without or with M.
avium at an MOI of 10 for 6 h. The blot was developed as described for panel B. Blots are representative of results obtained from three separate
experiments.
ASK1- and Caspase 8-dependent Apoptosis Triggered by M. avium26522
 by guest, on August 30, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
caspases 8, 9, and 3 was evident from the death-inhibitory
effects z-IETD-FMK, z-LEHD-FMK, and z-DEVD-FMK,
respectively.
Caspase Activities in M. avium-challenged J774A-1 Macro-
phages—Western blot analysis for cleaved, active caspases was
undertaken to determine caspase activation. Consistent with
the effect of caspase inhibitors on M. avium-induced cell death,
M. avium was found to activate the executioner caspase 3 (Fig.
3, panel A) and the initiator caspase 9 (Fig. 3, panel E) in a
time-dependent manner as evidenced by detection of the
cleaved, activated form of the caspases by Western blotting.
Caspase 3 activation was also supported by the detection of the
cleaved form of the caspase 3 substrate PARP in M. avium-
challenged macrophages (Fig. 3, panel C). The generation of
cleaved caspase 3 could be blocked by pretreatment with the
caspase 3-specific inhibitor z-DEVD-FMK as well as the
caspase 9-specific inhibitor z-LEHD-FMK (Fig. 3, panel B).
z-DEVD-FMK could also block the generation of cleaved PARP
in M. avium-challenged macrophages (Fig. 3, panel C). Gener-
ation of cleaved caspase 3 and cleaved caspase 9 could be
blocked by transfection of cells with ASK1(KM) (Fig. 3, panels
D and F, respectively). Generation of cleaved caspase 9 could
also be blocked by pretreating cells with the caspase 8-specific
inhibitor z-IETD-FMK (Fig. 3, panel E). These data supported
the role of ASK1 as well as caspase 8 in the activation of
caspase 9 and subsequent activation of caspase 3 in M. avium-
challenged macrophages. The role of caspase 8 as an initiator of
M. avium-induced death signaling was supported by Western
blotting analysis of pro- and active caspase 8. Cleaved caspase
8 was detected in M. avium-challenged macrophages (Fig. 3,
panel G). This could be blocked in cells pretreated with
the caspase 8-specific inhibitor z-IETD-FMK but not with the
caspase 3-specific inhibitor z-DEVD-FMK. M. avium-induced
caspase 8 activation was also blocked by pretreatment with the
p38 MAP kinase inhibitor SB203580 (Fig. 3, panel G) suggest-
ing a role of p38 MAP kinase in caspase 8 activation. The role
of FADD-mediated signaling was suggested by the fact that
caspase 8 activation was blocked in cells transfected with
FADD (dn) (Fig. 3, panel H). The data obtained from Western
blotting was further supported by caspase activity assays.
M. avium-induced activation of caspase 9 was abrogated in
cells transfected with ASK1(KM) or pretreated with the
caspase 8 inhibtor z-IETD-FMK (Fig. 4, panel A). Caspase 3
activation could also be abrogated in cells transfected with
ASK1(KM) or pretreated with the caspase 8 inhibtor z-IETD-
FMK or the caspase 9 inhibtor z-LEHD-FMK (Fig. 4, panel B).
Transfection with FADD (dn) blocked caspase 8 activation (Fig.
4, panel C). Western blotting and activity assays therefore
suggested that M. avium-triggered caspase 8 activation likely
involves FADD-dependent signaling. Of particular interest was
the observation that caspase 8 activation was blocked in cells
transfected with ASK1(KM) (Fig. 4, panel E). The p38 MAP
kinase inhibitor SB203580 also inhibited caspase 8 activation
in a dose-dependent manner both in untransfected (Fig. 4,
panel D) as well as in ASK1-transfected (Fig. 4, panel E) cells.
These results suggested that ASK1/p38 MAP kinase and FADD
signaling lead to caspase 8 activation.
Generation of Truncated Bid and Release of Cyt c—The ac-
tivation of caspase 9 in M. avium-challenged macrophages
suggested a role of the mitochondrial pathway in M. avium-
induced cell death. Taking into consideration that caspase 8
was also activated in M. avium-treated macrophages it ap-
peared likely that caspase 8 activation was linked to the mito-
chondrial death pathway. Linkage of caspase 8 to mitochon-
drial death signaling occurs through the caspase 8-mediated
cleavage of Bid and generation of t-Bid, which translocates to
the mitochondria and promotes the release of cyt c. We tested
whether M. avium-induced caspase 8 activation leads to sig-
naling to the mitochondria by the generation of t-Bid.
M. avium-treated macrophages showed time-dependent in-
crease of t-Bid in the mitochondrial fraction (Fig. 5, panel A,
upper blot). Generation of t-Bid was abrogated in caspase 8
inhibitor-treated- or in FADD(dn)-transfected cells (Fig. 5,
panel A, middle and lower blots), suggesting that t-Bid forma-
tion is dependent both on caspase 8 activation and on FADD.
Concomitant with this, cyt c was detected in the cytosol in a
time-dependent manner although the content of actin remained
the same (Fig. 5, panel B). Death signaling originating from
FADD-dependent caspase 8 activation was likely amplified by
mitochondrial cyt c release since pretreatment with the caspase
8 inhibitor z-IETD-FMK (Fig. 5, panel B) or transfection with
FADD (dn) (Fig. 5, panel C) abrogated M. avium-induced cyt c
release. Cyt c release was also blocked in cells transfected with
dominant-negative p38 MAP kinase (agf) or ASK(KM) (Fig. 5,
panel C), suggesting a role of ASK1/p38 MAP kinase signaling
not only in caspase 8 activation but also in mitochondrial cyt c
release in M. avium-challenged macrophages.
DISCUSSION
Previous reports have shown that macrophages infected with
mycobacteria undergo apoptosis and that apoptosis serves as a
mechanism of reducing bacillary viability. However, the sig-
nals leading to mycobacteria-induced host macrophage apo-
ptosis remain largely unknown. We have attempted to dissect
the mechanistic principles of mycobacteria-induced cell death
in the murine macrophage cell line J774A-1 that possesses
characteristics typical of macrophages (47). It has, in recent
years, been extensively used to study interactions of mycobac-
teria with macrophages (12, 49–50).
The diverse signals associated with apoptosis converge upon
the activation of procaspases which play a central role in the
initiation and execution of apoptosis. In the present study we
demonstrate that caspases 3, 8, and 9 are activated after chal-
lenge of macrophages with M. avium and that these are all
required for mycobacteria-induced death of J774A-1 macro-
phages. Inhibition of any one of these caspases with caspase-
FIG. 6. Proposed model for M. avium-induced ASK1- and
caspase 8-dependent cell death.
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specific peptide inhibitors was sufficient to block cell death.
Interestingly, we observed that the stress-activated MAP
kinase kinase kinase ASK1 is activated in M. avium-chal-
lenged macrophages. NAC inhibited M. avium-induced cell
death by inhibiting the activation of ASK1. However, it re-
mains to be elucidated whether the effect of NAC was due to
ROS-triggered sequential signaling leading to ASK1 activation
or due to dissociation of thioredoxin from ASK1. That ASK1
plays a central role in innate immunity against M. avium was
supported by the observation that a catalytically inactive mu-
tant of ASK1 could block M. avium-induced cell death. p38
MAP kinase appeared likely to be the downstream effector of
ASK1, since ASK1 activated p38 MAP kinase and a dominant-
negative mutant of p38 MAP kinase, or the p38 MAP kinase-
specific inhibitor SB203580 could block M. avium-induced cell
death. The link between ASK1/p38 MAP kinase signaling and
caspase activation was evident from the observation that a
catalytically inactive mutant of ASK1 could prevent activation
of caspases 8, 9, and 3. Treatment with SB203580 was also
associated with the inhibition of caspase 8 activation. Our
results suggest a role of ASK1/p38 signaling in caspase 8 acti-
vation. The release of cyt c from the mitochondria could be
blocked by caspase 8 inhibitor, suggesting that the death signal
triggered by caspase 8 activation is amplified by the mitochon-
drial release of cyt c. Cyt c release could also be blocked in p38
(agf)-transfected cells suggesting that ASK1/p38 MAP kinase
signaling plays a crucial role not only in activation of caspase 8
but also in downstream events leading to the release of cyt c
and activation of caspases 9 and 3 (Fig. 6). Caspase 3 inhibition
did not affect the activation of caspase 8 ruling out caspase 3 as
the mediator of caspase 8 activation.
In order to examine the role of FADD in M. avium-induced
signaling leading to cell death, we transfected cells with FADD
(dn) and examined downstream events. The role of FADD-de-
pendent signaling was demonstrated by the abrogation of
M. avium-induced caspase 8 activation and cell death in FADD
(dn)-transfected cells. However, FADD was not upstream of
ASK1/p38 MAP kinase activation since FADD (dn) transfection
did not affect M. avium-induced ASK1 and p38 MAP kinase
activation. Since death signals are in several instances ampli-
fied through the mitochondrial pathway by the caspase 8-me-
diated cleavage of Bid and its translocation to the mitochon-
dria, we analyzed the status of Bid in the mitochondrial
fractions of M. avium-challenged macrophages. Western blot-
ting showed an increase in the fraction of t-Bid in the mito-
chondria as a function of time of challenge with M. avium,
whereas caspase 8 inhibitor or FADD(dn) transfection could
block the generation of t-Bid in the mitochondrial fraction,
suggesting that FADD-dependent, and caspase 8-mediated Bid
cleavage activates the mitochondrial death pathway in this
case. This was supported by the concomitant detection of cyt c
in the cytosolic fraction.
Our results provide new insight into the role of ASK1 sig-
naling in cell death in macrophages and differ from the results
obtained with mink lung epithelial cells where ASK1-induced
apoptosis has been reported to occur through mitochondria-de-
pendent caspase activation in a caspase 8-independent manner
(51). Similar to our observations Raoul et al. (52) have demon-
strated the involvement of ASK1 and p38 MAP kinase together
with the classical FADD/caspase-8 pathway in the Fas-trig-
gered death of embryonic motor neurons, whereas Gilot et al.
(53) have demonstrated that hepatoprotection results from
both inhibition of the caspase cascade and prevention of ASK1-
JNK/p38 MAP kinase signaling.
We hypothesize that upon M. avium challenge, FADD-medi-
ated caspase 8 activation occurs downstream of ASK1/p38 MAP
kinase signaling (Fig. 6). ASK1/p38 MAP kinase signaling also
leads to the release of cyt c. Caspase 8-mediated cleavage of Bid
and its translocation to the mitochondria is probably associated
with the release of cyt c leading to the formation of an apo-
ptosome, activation of caspase 9 and finally to the execution of
apoptosis mediated by activation of caspase 3. Critical to the
activation of caspase 8 is the formation of the DISC. Since
ASK1 activates caspase 8, it is possible that ASK1 exerts its
effects upstream of the mitochondria probably at the level of
the formation of the DISC. Progression of the apoptotic signal
depends on an interplay of protein-protein interactions at dif-
ferent levels. Among these, cellular FLICE-like inhibitory pro-
tein (c-FLIP) prevents FADD-mediated apoptotic transduction
through inhibition of caspase 8 maturation (54–56). It appears
possible that ASK1 acts at the level of regulating c-FLIP activ-
ity. This could be at the level of synthesis or degradation of
c-FLIP or through its phosphorylation (57) as suggested in
recent reports. On the other hand, ASK1/p38 MAP kinase
signaling could also possibly regulate caspase 8 activity by
phosphorylating caspase 8 itself. However, to the best of our
knowledge, there are to date no reports of phosphorylation-de-
pendent activation of caspases. It is also possible that ASK1/
p38 MAP kinase signaling could lead to increased death recep-
tor ligand expression as documented in the case of p38 MAP
kinase-dependent overexpression of Fas ligand in intestinal
epithelial cells undergoing anoikis (48). Testing of these possi-
bilities is the subject of a separate investigation. The impor-
tance of the present investigation lies in the fact that it is the
first elucidation of a signaling pathway through which ASK1
plays a central role in innate immunity and therefore in the
containment of bacterial infection. It also one of the few recent
reports of the ASK1-dependent regulation of caspase 8
activation.
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